Drugs / DT vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01993173 Comparator | Nov 2013 → Feb 2014 | diphtheria, pertussis, tetanus | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DT vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01993173 ↗ |
| Modality | Vaccine | “DT vaccine (Diphtheria and Tetanus Combined Vaccine, Adsorbed)” NCT01993173 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT01993173 ↗ |